Absorbable Plain Gut Suture Market Size, Share, Growth, and Industry Analysis, By Type (Collagen Suture, Catgut, Others), By Application (General Surgery, Obstetrics And Gynecology, Oral And Maxillofacial Surgery, Urology, Others), Regional Insights and Forecast to 2035

Absorbable Plain Gut Suture Market Overview

The global Absorbable Plain Gut Suture Market size estimated at USD 185.2 million in 2026 and is projected to reach USD 320.05 million by 2035, growing at a CAGR of 6.27% from 2026 to 2035.

The Absorbable Plain Gut Suture Market remains an important segment of the global surgical sutures industry, driven by increasing surgical procedures and demand for naturally absorbable wound closure materials. Absorbable plain gut sutures are manufactured from purified collagen obtained from animal connective tissues and typically retain tensile strength for nearly 7 days while complete absorption occurs within 70 days. More than 313 million surgical procedures are performed globally every year, creating sustained demand for absorbable sutures. Plain gut sutures account for approximately 18% of absorbable natural suture utilization in hospitals. Growing outpatient surgeries, increasing cesarean section procedures exceeding 31 million annually, and expanding healthcare infrastructure continue to support market expansion across developed and emerging healthcare systems.

The United States represents a major market for absorbable plain gut sutures due to its large surgical volume and advanced healthcare infrastructure. More than 51 million inpatient surgical procedures and 48 million ambulatory surgeries are conducted annually across the country. Approximately 32% of wound closure procedures in community hospitals utilize absorbable sutures. The country operates over 6,100 hospitals and more than 11,000 ambulatory surgical centers. Around 3.7 million births occur annually, with cesarean delivery rates reaching 32%, creating significant demand for absorbable plain gut sutures in obstetric procedures. Orthopedic, gastrointestinal, gynecological, and urological surgeries collectively account for over 67% of absorbable suture consumption across U.S. healthcare facilities.

Download Free Sample to learn more about this report.

Key Findings

• Key Market Driver: More than 64% of surgeons prefer absorbable wound closure materials, while procedural adoption rates exceed 58% in general surgery and 62% in obstetric procedures, supporting strong utilization percentages worldwide.
• Major Market Restraint: Synthetic absorbable sutures account for 71% preference in advanced healthcare facilities, while plain gut utilization has declined by 19% in selected high-volume surgical centers due to performance considerations.
• Emerging Trends: Antibacterial-coated absorbable sutures show adoption growth of 43%, while minimally invasive surgery applications contribute 37% of absorbable suture demand and specialized wound closure procedures represent 29%.
• Regional Leadership: North America holds approximately 39% market share, Europe contributes 28%, Asia-Pacific represents 24%, and Middle East & Africa accounts for 9% of global absorbable plain gut suture consumption.
• Competitive Landscape: The five largest manufacturers collectively control 68% market share, while the leading two companies account for 41% and regional manufacturers contribute approximately 22% of total supply.
• Market Segmentation: General surgery contributes 36% of utilization, obstetrics and gynecology account for 24%, oral surgery represents 15%, urology reaches 11%, and other applications comprise 14%.
• Recent Development: Product portfolio expansion activities increased by 31%, manufacturing capacity enhancement projects rose 27%, regulatory approvals advanced 18%, and sustainability-focused initiatives accounted for 21% of industry developments.

Absorbable Plain Gut Suture Market Latest Trends

The Absorbable Plain Gut Suture Market is witnessing significant transformation due to evolving surgical practices and increasing demand for efficient wound management solutions. Minimally invasive surgeries currently account for nearly 54% of selected surgical interventions globally, increasing demand for absorbable closure products. Hospitals represent approximately 72% of total absorbable plain gut suture consumption, while ambulatory surgical centers contribute 19%. Demand from gynecological procedures has increased by 16% during recent years due to rising cesarean section volumes exceeding 31 million procedures annually worldwide. Healthcare facilities are emphasizing infection prevention, leading to increased procurement of premium absorbable sutures in nearly 48% of tertiary care institutions. Digital inventory management systems are now used by 57% of major hospitals, improving suture procurement efficiency. Emerging economies contribute approximately 42% of global surgical procedure growth, creating substantial opportunities for absorbable plain gut suture suppliers. Product standardization and compliance initiatives have expanded, with over 85 countries adopting harmonized medical device regulations. Furthermore, surgical training programs involving absorbable sutures have expanded by 23%, improving surgeon familiarity and procedural confidence. These trends continue to shape purchasing decisions and influence market penetration across healthcare settings.

Absorbable Plain Gut Suture Market Dynamics

DRIVER

" Rising volume of surgical procedures worldwide."

The primary growth driver for the Absorbable Plain Gut Suture Market is the continuous increase in global surgical volumes. More than 313 million surgeries are conducted annually worldwide, with gastrointestinal procedures accounting for 21%, orthopedic procedures 18%, and obstetric interventions 15%. Absorbable sutures are used in approximately 63% of soft tissue closure applications. Growing access to healthcare has increased hospital admissions by 14% in developing regions. More than 140 million trauma-related injuries require medical intervention each year, creating additional demand for wound closure products. Aging populations further support growth, as individuals above 65 years account for nearly 42% of surgical admissions in developed healthcare systems. Increased healthcare expenditure and expanding surgical infrastructure continue to strengthen market demand.

RESTRAINT

" Growing preference for synthetic absorbable sutures."

The market faces pressure from increasing adoption of synthetic absorbable sutures. Approximately 71% of advanced surgical centers prefer synthetic alternatives because of predictable absorption profiles and extended tensile strength retention. Surveys indicate that 58% of surgeons select synthetic absorbable sutures for high-tension closures. Synthetic products maintain tensile strength for periods exceeding 21 days, while plain gut variants typically retain effective strength for around 7 days. Nearly 46% of procurement departments prioritize synthetic options due to standardized performance characteristics. Regulatory requirements related to biological raw materials have also increased compliance obligations by 24%, creating additional operational challenges for manufacturers operating in the absorbable plain gut suture segment.

OPPORTUNITY

" Expansion of healthcare infrastructure in emerging economies."

Emerging economies present significant opportunities for market participants. More than 4.2 billion people reside in regions where healthcare infrastructure continues to expand rapidly. Hospital construction projects increased by 18% across Asia-Pacific and 14% across selected African countries. Government healthcare modernization programs have expanded surgical capacity by 22% in multiple developing markets. Medical tourism destinations perform over 6 million international procedures annually, increasing demand for cost-effective absorbable sutures. Public healthcare investments have increased operating room availability by 17% in emerging economies. These developments create substantial opportunities for absorbable plain gut suture manufacturers seeking broader geographic penetration and higher procedural utilization rates.

CHALLENGE

"Maintaining consistent biological raw material quality."

One of the major challenges in the Absorbable Plain Gut Suture Market is ensuring consistent quality of collagen-derived raw materials. Quality control protocols account for nearly 12% of production activities. Regulatory inspections related to biological sourcing increased by 26% during recent years. Manufacturers must comply with sterilization standards achieving microbial reduction levels above 99.9999%. Supply chain disruptions affecting biological materials impacted approximately 15% of production facilities globally. Traceability requirements now cover nearly 100% of animal-derived medical products in major markets. These factors increase operational complexity and require substantial investment in quality assurance systems and regulatory compliance programs.

Absorbable Plain Gut Suture Market Segmentation 

The Absorbable Plain Gut Suture Market is segmented by type and application to address diverse surgical requirements. By type, collagen sutures account for approximately 46% market share, catgut products represent 39%, and other specialized variants contribute 15%. By application, general surgery leads with 36% share, followed by obstetrics and gynecology at 24%, oral and maxillofacial surgery at 15%, urology at 11%, and other procedures at 14%. Growing surgical specialization and increasing procedural volumes continue to influence segment performance. Healthcare facilities increasingly select products based on wound type, tissue characteristics, and expected healing duration, driving segmentation diversity across global healthcare systems.

Download Free Sample to learn more about this report.

By Type

Collagen Suture: Collagen sutures account for approximately 46% of the Absorbable Plain Gut Suture Market. These products are widely used because of their biocompatibility and reliable absorption characteristics. More than 61% of soft tissue approximation procedures utilizing natural absorbable materials involve collagen-based sutures. Tensile strength retention remains effective for approximately 7 days, supporting wound healing requirements in low-tension surgical applications. Hospitals represent nearly 74% of collagen suture procurement. Growing demand from gynecological and gastrointestinal surgeries contributes significantly to utilization levels. Enhanced purification technologies have improved product consistency by 22%, supporting increased adoption across healthcare institutions worldwide.

Catgut: Catgut sutures represent approximately 39% market share and remain widely utilized in traditional surgical procedures. More than 29 million surgical interventions annually involve natural absorbable closure materials, with catgut products maintaining a significant presence. Their complete absorption generally occurs within 70 days, making them suitable for temporary tissue support. Developing healthcare systems account for nearly 57% of catgut utilization due to affordability and availability. Veterinary surgical applications contribute an additional 8% of demand. Improvements in sterilization technologies have enhanced product safety standards across manufacturing facilities operating in the catgut segment.

Others: Other absorbable plain gut suture variants contribute approximately 15% of market share. These products include specialized natural absorbable formulations developed for specific surgical applications. Specialty procedures account for nearly 18% of utilization within this category. Adoption rates have increased by 12% due to growing demand for customized wound closure solutions. Ambulatory surgical centers contribute approximately 21% of procurement within this segment. Technological improvements in packaging, sterilization, and product handling have increased usability and storage efficiency, supporting broader acceptance among healthcare professionals globally.

By Application

General Surgery: General surgery accounts for approximately 36% of total market demand. More than 110 million general surgical procedures are conducted annually worldwide. Gastrointestinal surgeries, hernia repairs, and soft tissue procedures represent major utilization areas. Approximately 63% of selected tissue closure applications within general surgery use absorbable materials. Hospitals remain the primary procurement channel, accounting for nearly 81% of product consumption in this segment.

Obstetrics And Gynecology: Obstetrics and gynecology contribute approximately 24% of market share. More than 31 million cesarean sections are performed globally each year, creating substantial demand for absorbable sutures. Gynecological surgeries account for an additional 18 million procedures annually. Absorbable plain gut sutures are frequently selected for internal tissue closure due to their natural absorption characteristics. Women's health facilities contribute nearly 27% of segment procurement.

Oral And Maxillofacial Surgery: Oral and maxillofacial surgery represents approximately 15% of market demand. More than 12 million dental extraction procedures involving surgical closure are conducted annually across major healthcare markets. Absorbable sutures eliminate removal requirements, improving patient convenience. Dental hospitals and specialized clinics account for approximately 68% of procurement in this application category.

Urology: Urology contributes approximately 11% market share. More than 26 million urological procedures are performed globally each year. Absorbable plain gut sutures are commonly utilized in low-tension tissue approximation procedures. Hospitals account for approximately 79% of procurement. Growing incidence of urinary tract disorders and increasing surgical interventions continue supporting segment demand.

Others: Other applications represent approximately 14% of market utilization. These include veterinary surgeries, dermatological procedures, and specialty surgical interventions. Veterinary applications account for nearly 6% of this category. Expanding outpatient procedure volumes and increasing specialty clinic numbers continue supporting demand. Utilization has increased by 13% across selected healthcare systems due to broader procedural adoption.

Absorbable Plain Gut Suture Market Regional Outlook

The global Absorbable Plain Gut Suture Market demonstrates strong regional diversity. North America leads with approximately 39% market share due to high surgical volumes and advanced healthcare systems. Europe follows with 28%, supported by established hospital networks and standardized surgical practices. Asia-Pacific accounts for 24%, driven by expanding healthcare access and growing patient populations. Middle East & Africa contribute 9%, supported by healthcare modernization initiatives and increasing surgical infrastructure investments. Regional growth patterns are closely linked to hospital capacity expansion, surgical procedure frequency, healthcare workforce availability, and adoption of absorbable wound closure technologies.

Download Free Sample to learn more about this report.

NORTH AMERICA

North America holds approximately 39% of the global Absorbable Plain Gut Suture Market. The region performs more than 80 million surgical procedures annually, creating substantial demand for absorbable wound closure materials. The United States accounts for nearly 84% of regional consumption, supported by over 6,100 hospitals and 11,000 ambulatory surgical centers. Canada contributes approximately 11% of regional demand, while Mexico represents 5%. General surgery accounts for 37% of absorbable plain gut suture utilization across North America. Obstetric procedures contribute approximately 23%, supported by more than 3.7 million annual births in the United States alone. Hospital procurement departments increasingly focus on infection prevention and procedural efficiency, leading to consistent demand for absorbable closure products. More than 69% of tertiary healthcare institutions maintain dedicated procurement contracts for absorbable sutures. Technological advancements in surgical procedures and increased healthcare accessibility continue supporting market stability. Regulatory compliance standards remain among the most stringent globally, ensuring high product quality and safety across healthcare facilities.

EUROPE

Europe accounts for approximately 28% of the global Absorbable Plain Gut Suture Market. The region performs more than 72 million surgical procedures annually. Germany, France, the United Kingdom, Italy, and Spain collectively contribute nearly 76% of regional demand. Hospital networks across Europe comprise more than 15,000 healthcare facilities utilizing absorbable wound closure products. General surgery procedures account for approximately 34% of suture consumption, while gynecological procedures contribute 25%. Public healthcare systems support broad access to surgical services, enhancing utilization levels. More than 62% of healthcare facilities utilize centralized procurement systems for surgical consumables. Regulatory harmonization across European healthcare markets supports consistent product standards and market access. The aging population remains a key demand contributor, with individuals above 65 years representing approximately 21% of the regional population. Surgical intervention rates continue increasing, supporting stable absorbable plain gut suture demand across public and private healthcare institutions.

ASIA-PACIFIC

Asia-Pacific represents approximately 24% of the Absorbable Plain Gut Suture Market and remains the fastest expanding regional segment in terms of procedural volume. The region accounts for more than 60% of the global population and performs over 120 million surgical procedures annually. China, India, Japan, South Korea, and Australia collectively contribute approximately 81% of regional demand. Healthcare infrastructure investments have increased hospital capacity by 18% in major economies. More than 42,000 hospitals operate across key Asia-Pacific countries, supporting substantial procedural volumes. Obstetric and gynecological procedures contribute nearly 29% of absorbable plain gut suture utilization due to high birth volumes. Government healthcare expansion initiatives have increased surgical access for millions of patients. Medical tourism destinations perform more than 6 million international procedures annually, further supporting demand. Cost-effective natural absorbable sutures remain attractive in price-sensitive healthcare markets. Increasing surgeon training programs and modernization of operating facilities continue strengthening regional market development.

MIDDLE EAST & AFRICA

The Middle East & Africa account for approximately 9% of the global Absorbable Plain Gut Suture Market. Healthcare modernization initiatives and hospital expansion projects continue supporting demand across the region. More than 8,000 hospitals operate throughout major Middle Eastern and African countries. Surgical procedure volumes exceed 18 million annually, with general surgery representing approximately 38% of utilization. Gulf Cooperation Council countries contribute nearly 47% of regional demand due to advanced healthcare infrastructure and increasing medical tourism activities. Public healthcare investments have increased operating room capacity by 16% across selected markets. Africa represents significant long-term potential due to a population exceeding 1.4 billion. Government healthcare programs continue expanding access to surgical care. International healthcare partnerships have improved training opportunities for surgeons and operating room staff. Demand for cost-effective absorbable wound closure materials remains strong, particularly in public healthcare institutions serving large patient populations.

List of Top Absorbable Plain Gut Suture Companies

• Ethicon (Johnson & Johnson)
• Medtronic (Covidien)
• B. Braun Medical Inc.
• Teleflex Incorporated
• Look® (Assut Europe S.p.A.)
• Hu-Friedy
• Surgical Specialties Corporation
• STERIS Corporation
• UNIGUT

List of Top 2 Companies Market Share

Ethicon (Johnson & Johnson): Approximately 24% market share, supported by distribution across more than 175 countries and extensive surgical product portfolios.

Medtronic (Covidien): Approximately 17% market share, supported by global manufacturing operations and broad penetration across hospital procurement networks.

Investment Analysis and Opportunities

Investment activity in the Absorbable Plain Gut Suture Market is focused on manufacturing modernization, sterilization technologies, supply chain optimization, and expansion into emerging healthcare markets. More than 43% of industry investments are directed toward production efficiency improvements. Automated manufacturing systems have increased output capacity by 26% across selected facilities. Healthcare infrastructure expansion projects in developing economies continue creating procurement opportunities. More than 18,000 hospital construction and modernization projects are active globally. Surgical procedure growth exceeding 14 million additional annual interventions in emerging markets creates sustained demand for absorbable wound closure products. Investments in quality control technologies have improved production consistency by 21%. Strategic partnerships between healthcare distributors and manufacturers increased by 17%. Regional manufacturing facilities reduce logistics costs and improve supply reliability. Increasing adoption of ambulatory surgical centers, which now perform approximately 35% of selected procedures, presents additional procurement opportunities. Market participants continue investing in training programs, distribution networks, and regulatory compliance initiatives to strengthen competitive positioning.

New Product Development

Product development efforts within the Absorbable Plain Gut Suture Market focus on improving handling characteristics, packaging efficiency, sterility assurance, and tissue compatibility. More than 28% of recent product innovation projects target enhanced knot security and reduced tissue drag. Advanced sterilization techniques have increased shelf-life stability by 19%. Manufacturers are introducing precision-engineered needle-suture combinations that improve procedural efficiency by 16%. Research programs involving collagen purification technologies have reduced material variability by 22%. Packaging innovations have improved storage durability and reduced contamination risks. More than 31% of newly launched products emphasize user convenience and operating room efficiency. Digital traceability systems integrated into packaging support compliance requirements and inventory management. Specialized absorbable plain gut sutures designed for gynecological and oral surgery applications continue gaining attention among healthcare providers. Product differentiation strategies increasingly focus on procedural performance, reliability, and compliance with international quality standards.

Five Recent Developments (2023-2025)

• In 2023, major manufacturers expanded absorbable suture production capacity by approximately 18% to address increasing surgical procedure volumes.
• In 2023, advanced sterilization validation programs improved microbial reduction performance to levels exceeding 99.9999% across multiple production facilities.
• In 2024, new packaging systems reduced product handling time by 14% and enhanced storage efficiency in hospital supply chains.
• In 2024, several manufacturers implemented automated quality inspection technologies, increasing defect detection accuracy by 27%.
• In 2025, expanded distribution agreements improved product availability across more than 40 additional healthcare markets worldwide.

Report Coverage of Absorbable Plain Gut Suture Market

This report provides comprehensive coverage of the Absorbable Plain Gut Suture Market across product categories, applications, regional markets, competitive developments, and industry trends. The study evaluates market performance across collagen sutures, catgut products, and specialized absorbable variants. Analysis includes general surgery, obstetrics and gynecology, oral and maxillofacial surgery, urology, and additional healthcare applications. The report examines utilization patterns across hospitals, ambulatory surgical centers, specialty clinics, and other healthcare institutions. More than 313 million annual surgical procedures are assessed as key demand indicators. Regional evaluation covers North America, Europe, Asia-Pacific, and Middle East & Africa, representing 100% of global market activity. Competitive assessment includes leading manufacturers, product portfolios, manufacturing capabilities, and market positioning. The report also reviews investment activities, technology developments, regulatory influences, quality standards, supply chain factors, and healthcare infrastructure trends shaping future demand for absorbable plain gut sutures across global healthcare systems.